Curative Effect Study of Endostatin Combined With Chemoradiotherapy to Non-small-cell Lung Cancer
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
To evaluate the efficacy and safety of Endostar combined with concurrent chemo-radiotherapy
(CCRT) in patients with unresectable stage III non-small-cell lung cancer (NSCLC).
Phase:
Phase 2
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
Fifth Affiliated Hospital, Sun Yat-Sen University Fujian Province Tumor Hospital Guangxi Medical University Guangzhou General Hospital of Guangzhou Military Command The 458 Hospital of Chinese PLA The Affiliated Hospital of Guangdong Medical College The Affiliated Tumor Hospital of Guangxi Medical University Zhejiang Cancer Hospital